Hospira (HSP) Tops Q4 EPS by 11c

Hospira (NYSE: HSP) reported Q4 EPS of $0.53, $0.11 better than the analyst estimate of $0.42. Revenue for the quarter came in at $1.13 billion versus the consensus estimate of $1.12 billion.

For earnings history and earnings-related data on Hospira (HSP) click here.

You May Also Be Interested In

• Otter Tail Corp (OTTR) Tops Q2 EPS by 15c; offers guidance
• New Jersey Resources (NJR) Tops Q3 EPS by 7c; offers guidance
• aTyr Pharma (LIFE) Reports Q2 EPS of $0.53 ; Offers Guidance